Global Health Strategies provides strategic communications services to help our clients reach opinion-leading journalists, inform key policymakers, and shape global public opinion.

Recent press coverage of our clients by subject area includes:

VACCINES

• The New York Times editorial on the benefit of the vaccine industry and GlaxoSmithKline Biologicals' successful candidate malaria vaccine
  
  
• Business Week's feature story on GlaxoSmithKline Biologicals' new Rotavirus vaccine
  
  
• France's Liberation on the announcement of successful results of clinical trial for a new malaria vaccine candidate
  
  
• Financial Times coverage of a new HIV vaccine trial jointly run by Merck and the HIV Vaccine Trials Network
  
  

AIDS

• The Wall Street Journal's front page coverage of the shortage of trained healthcare workers to deliver antiretroviral drugs in Asia
  


• New York Times coverage of a report published by amfAR's TREAT Asia Network at the 2004 International AIDS Conference in Bangkok
  
  
• USA Today on the dramatic increase in the HIV infection rate in Vietnam
  
  

MICROBICIDES

• The New York Times letter by IPM CEO Zeda Rosenberg calling for the development of new women-initiated HIV prevention technologies
  
  
• The Economist piece calling microbicides "one of the most promising ideas being discussed at the AIDS conference in Bangkok"
  
  
• The Toronto Globe and Mail's recent editorial calling on the Canadian government to support micrbocide development
  
  
• The Arizona Republic's recent editorial calling on the US government to support microbicide development
  
  
• The New York Times on recent progress in microbicide research and development
  

REPORTS

• GHS recently worked with amfAR's TREAT Asia program to create a Special TREAT Asia Report on the urgent shortage of trained doctors in Asia that was released at the 2004 Bangkok AIDS conference